Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2024

15-11-2023 | Eosinophilic Esophagitis | Original Article

Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years

Authors: Akshatha Kiran, Brenderia A. Cameron, Zeyun Xue, Sean LaFata, Adolfo A. Ocampo, Justin McCallen, Christopher J. Lee, Stephanie A. Borinsky, Walker D. Redd, Cary C. Cotton, Swathi Eluri, Craig C. Reed, Evan S. Dellon

Published in: Digestive Diseases and Sciences | Issue 2/2024

Login to get access

Abstract

Background

The presentation of eosinophilic esophagitis (EoE) is heterogeneous, but trends over time are not known.

Aim

To determine whether clinical and endoscopic phenotypes at EoE diagnosis have changed over the past 2 decades.

Methods

In this retrospective cohort study, adults and children with newly diagnosed EoE were phenotyped as follows: (1) inflammatory vs fibrostenotic vs mixed on endoscopy; (2) atopic vs non-atopic; (3) age at symptom onset; (4) age at diagnosis; (5) presence of autoimmune or connective tissue disease; and (6) responsive to steroids. The prevalence of different phenotypes was categorized by 5-year intervals. Multivariate analysis was performed to assess for changes in patient features over time.

Results

Of 1187 EoE patients, age at diagnosis increased over time (from 22.0 years in 2002–2006 to 31.8 years in 2017–2021; p < 0.001) as did the frequency of dysphagia (67% to 92%; p < 0.001). Endoscopic phenotypes were increasingly mixed (26% vs 68%; p < 0.001) and an increasing proportion of patients had later onset of EoE. However, there were no significant trends for concomitant autoimmune/connective tissue disease or steroid responder phenotypes. On multivariate analysis, after accounting for age, dysphagia, and food impaction, the increase in the mixed endoscopic phenotype persisted (aOR 1.51 per each 5-year interval, 95% CI 1.31–1.73).

Conclusion

EoE phenotypes have changed over the past two decades, with increasing age at diagnosis and age at symptom onset. The mixed endoscopic phenotype also increased, even after controlling for age and symptomatology. Whether this reflects changes in provider recognition or disease pathophysiology is yet to be elucidated.
Literature
2.
go back to reference Dellon ES, Liacouras CA, Molina-Infante J et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022–1033.PubMed Dellon ES, Liacouras CA, Molina-Infante J et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022–1033.PubMed
3.
go back to reference Ruffner MA, Cianferoni A. Phenotypes and endotypes in eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2020;124:233–239.PubMed Ruffner MA, Cianferoni A. Phenotypes and endotypes in eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2020;124:233–239.PubMed
4.
go back to reference Chehade M, Jones SM, Pesek RD et al. Phenotypic characterization of eosinophilic esophagitis in a large multi-center patient population from the consortium for food allergy research. J Allergy Clin Immunol 2018;6:1534–1544. Chehade M, Jones SM, Pesek RD et al. Phenotypic characterization of eosinophilic esophagitis in a large multi-center patient population from the consortium for food allergy research. J Allergy Clin Immunol 2018;6:1534–1544.
5.
go back to reference Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.e6.PubMed Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.e6.PubMed
6.
go back to reference Laserna-Mendieta EJ, Navarro P, Casabona-Francés S et al. Differences between childhood- and adulthood-onset eosinophilic esophagitis: an analysis from the EoE CONNECT registry. Dig Liver Dis. 2023;55:350–359.PubMed Laserna-Mendieta EJ, Navarro P, Casabona-Francés S et al. Differences between childhood- and adulthood-onset eosinophilic esophagitis: an analysis from the EoE CONNECT registry. Dig Liver Dis. 2023;55:350–359.PubMed
7.
go back to reference Dellon ES, Kim HP, Sperry SLW et al. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointestinal Endosc. 2014;79:577-585.e4. Dellon ES, Kim HP, Sperry SLW et al. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointestinal Endosc. 2014;79:577-585.e4.
8.
go back to reference Lyles JL, Martin LJ, Shoda T et al. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. J Allergy Clin Immunol. 2021;147:244-254.e6.PubMed Lyles JL, Martin LJ, Shoda T et al. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. J Allergy Clin Immunol. 2021;147:244-254.e6.PubMed
9.
go back to reference Shoda T, Wen T, Aceves SS et al. Eosinophilic esophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Lancet Gastroenterol Hepatol. 2018;3:477–488.PubMedPubMedCentral Shoda T, Wen T, Aceves SS et al. Eosinophilic esophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Lancet Gastroenterol Hepatol. 2018;3:477–488.PubMedPubMedCentral
10.
go back to reference Greenberg SB, Ocampo AA, Xue Z et al. Increasing rates of esophageal stricture and dilation over two decades in eosinophilic esophagitis. Gastro Hep Adv. 2023;2:521–523.PubMed Greenberg SB, Ocampo AA, Xue Z et al. Increasing rates of esophageal stricture and dilation over two decades in eosinophilic esophagitis. Gastro Hep Adv. 2023;2:521–523.PubMed
11.
go back to reference Lipka S, Kumar A, Richter JE. Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol. 2016;50:134–140.PubMed Lipka S, Kumar A, Richter JE. Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol. 2016;50:134–140.PubMed
12.
go back to reference Hill DA, Grundmeier RW, Ramos M et al. Eosinophilic esophagitis is a late manifestation of the allergic. J Allergy Clin Immunol 2018;6:1528–1533. Hill DA, Grundmeier RW, Ramos M et al. Eosinophilic esophagitis is a late manifestation of the allergic. J Allergy Clin Immunol 2018;6:1528–1533.
13.
go back to reference Hill DA, Dudley JW, Spergel JM. The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol. 2017;5:369–375. Hill DA, Dudley JW, Spergel JM. The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol. 2017;5:369–375.
14.
go back to reference Abonia JP, Wen T, Stucke EM et al. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013;132:378–386.PubMed Abonia JP, Wen T, Stucke EM et al. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013;132:378–386.PubMed
15.
go back to reference Talathi S, Knight T, Dimmitt R et al. Concurrent eosinophilic esophagitis in pediatric patients with inflammatory bowel disease: a case series. Ann Allergy Asthma Immunol. 2019;123:313–316.PubMed Talathi S, Knight T, Dimmitt R et al. Concurrent eosinophilic esophagitis in pediatric patients with inflammatory bowel disease: a case series. Ann Allergy Asthma Immunol. 2019;123:313–316.PubMed
16.
go back to reference Reed CC, Corder SR, Kim E et al. Psychiatric comorbidities and psychiatric medication use are highly prevalent in patients with eosinophilic esophagitis and associate with clinical presentation. Am J Gastroenterol. 2020;115:853–858.PubMedPubMedCentral Reed CC, Corder SR, Kim E et al. Psychiatric comorbidities and psychiatric medication use are highly prevalent in patients with eosinophilic esophagitis and associate with clinical presentation. Am J Gastroenterol. 2020;115:853–858.PubMedPubMedCentral
17.
go back to reference Dellon ES, Gibbs WB, Fritchie KJ et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305.PubMedPubMedCentral Dellon ES, Gibbs WB, Fritchie KJ et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305.PubMedPubMedCentral
18.
go back to reference Noel RJ, Putnam PE, Collins MH et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575.PubMed Noel RJ, Putnam PE, Collins MH et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575.PubMed
19.
go back to reference Munoz-Osores E, Maldonado-Campos I, Olivares-Labbe MT et al. Corticosteroids for eosinophilic esophagitis in children: a meta-analysis. Pediatrics 2020;146:e20200874.PubMed Munoz-Osores E, Maldonado-Campos I, Olivares-Labbe MT et al. Corticosteroids for eosinophilic esophagitis in children: a meta-analysis. Pediatrics 2020;146:e20200874.PubMed
20.
go back to reference Nhu QM, Aceves SS. Medical and dietary management of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2018;121:156–161.PubMed Nhu QM, Aceves SS. Medical and dietary management of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2018;121:156–161.PubMed
21.
go back to reference Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109–116.PubMed Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109–116.PubMed
22.
go back to reference Kiran A, Dellon ES, Reed CC. Symptoms do not discriminate between elderly patients with and without eosinophilic esophagitis. Gastroenterology. In press, 2023. Sa1285. Kiran A, Dellon ES, Reed CC. Symptoms do not discriminate between elderly patients with and without eosinophilic esophagitis. Gastroenterology. In press, 2023. Sa1285.
23.
go back to reference Kiran A, Dellon ES, Reed CC. Older patients with esophageal symptoms are less likely to have diagnostic biopsies for eosinophilic esophagitis. Gastroenterology 2022;162:Su1195. Kiran A, Dellon ES, Reed CC. Older patients with esophageal symptoms are less likely to have diagnostic biopsies for eosinophilic esophagitis. Gastroenterology 2022;162:Su1195.
25.
go back to reference Wolf WA, Cotton CC, Green DJ et al. Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol. 2015;13:452–458.PubMed Wolf WA, Cotton CC, Green DJ et al. Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol. 2015;13:452–458.PubMed
26.
go back to reference Eluri S, Selitsky SR, Perjar I et al. Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17:1081-1088.e2.PubMed Eluri S, Selitsky SR, Perjar I et al. Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17:1081-1088.e2.PubMed
27.
go back to reference Dellon ES, Tsai YS, Coffey AR et al. Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis. Dis Esophagus 2023;36:71. Dellon ES, Tsai YS, Coffey AR et al. Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis. Dis Esophagus 2023;36:71.
28.
go back to reference Jensen ET, Langefeld CD, Zimmerman KD et al. Epigenetic methylation in eosinophilic esophagitis: molecular ageing and novel biomarkers for treatment response. Clin Exp Allergy 2020;50:1372–1380.PubMed Jensen ET, Langefeld CD, Zimmerman KD et al. Epigenetic methylation in eosinophilic esophagitis: molecular ageing and novel biomarkers for treatment response. Clin Exp Allergy 2020;50:1372–1380.PubMed
29.
go back to reference Ketchem C, Thakkar KP, Reddy S et al. Older patients with eosinophilic esophagitis have high rates of treatment response to topical steroids. Dig Liver Dis. 2022;54:477–482.PubMed Ketchem C, Thakkar KP, Reddy S et al. Older patients with eosinophilic esophagitis have high rates of treatment response to topical steroids. Dig Liver Dis. 2022;54:477–482.PubMed
30.
go back to reference Sperry SLW, Woosley JT, Shaheen NJ et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:215–221.PubMed Sperry SLW, Woosley JT, Shaheen NJ et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:215–221.PubMed
31.
go back to reference Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.PubMed Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.PubMed
32.
go back to reference Dellon ES, Gonsalves N, Hirano I et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692.PubMed Dellon ES, Gonsalves N, Hirano I et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692.PubMed
33.
go back to reference Hirano I, Moy N, Heckman MG et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–495.PubMed Hirano I, Moy N, Heckman MG et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–495.PubMed
34.
go back to reference Dellon ES, Cotton CC, Gebhart JH et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clinical Gastroenterology and Hepatology. 2016;14:31–39.PubMed Dellon ES, Cotton CC, Gebhart JH et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clinical Gastroenterology and Hepatology. 2016;14:31–39.PubMed
35.
go back to reference Ma C, Bredenoord AJ, Dellon ES et al. Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointestinal Endoscopy. 2022;95:1126-1137.e2.PubMed Ma C, Bredenoord AJ, Dellon ES et al. Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointestinal Endoscopy. 2022;95:1126-1137.e2.PubMed
36.
go back to reference Redd WD, Ocampo AA, Xue Z et al. Eosinophilic esophagitis patients with multiple atopic conditions: clinical characteristics and treatment response to topical steroids. Ann Allergy Asthma Immunol. 2023;S1081–1206:00311–00313. Redd WD, Ocampo AA, Xue Z et al. Eosinophilic esophagitis patients with multiple atopic conditions: clinical characteristics and treatment response to topical steroids. Ann Allergy Asthma Immunol. 2023;S1081–1206:00311–00313.
37.
go back to reference Xue Z, Miller TL, Abramson L et al. Association of eosinophilic esophagitis with autoimmune and connective tissue disorders, and the impact on treatment response. Dis Esophagus. 2022;36:43. Xue Z, Miller TL, Abramson L et al. Association of eosinophilic esophagitis with autoimmune and connective tissue disorders, and the impact on treatment response. Dis Esophagus. 2022;36:43.
38.
go back to reference Wolf WA, Cotton CC, Green DJ et al. Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis. J Gastroenterol Hepatol Res. 2015;4:1780–1787.PubMedPubMedCentral Wolf WA, Cotton CC, Green DJ et al. Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis. J Gastroenterol Hepatol Res. 2015;4:1780–1787.PubMedPubMedCentral
39.
go back to reference Reed CC, Wolf WA, Cotton CC et al. Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study. Clin Gastroenterol Hepatol. 2018;16:226–233.PubMed Reed CC, Wolf WA, Cotton CC et al. Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study. Clin Gastroenterol Hepatol. 2018;16:226–233.PubMed
40.
go back to reference Dellon ES, Gupta SK. A conceptual approach to understanding treatment response in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17:2149–2160.PubMedPubMedCentral Dellon ES, Gupta SK. A conceptual approach to understanding treatment response in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17:2149–2160.PubMedPubMedCentral
41.
go back to reference Schoepfer AM, Safroneeva E, Bussmann C et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230-1236.e2.PubMed Schoepfer AM, Safroneeva E, Bussmann C et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230-1236.e2.PubMed
42.
go back to reference Warners MJ, Oude Nijhuis RAB, De Wijkerslooth LRH et al. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836–844.PubMed Warners MJ, Oude Nijhuis RAB, De Wijkerslooth LRH et al. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836–844.PubMed
43.
go back to reference Chang NC, Thakkar KP, Ketchem CJ et al. A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients. Clin Gastroenterol Hepatol. 2022;20:1701-1708.e2.PubMed Chang NC, Thakkar KP, Ketchem CJ et al. A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients. Clin Gastroenterol Hepatol. 2022;20:1701-1708.e2.PubMed
44.
go back to reference Hoofien A, Papadopoulou A, Gutiérrez-Junquera C et al. Sustained remission of eosinophilic esophagitis following discontinuation of dietary elimination in children. Clin Gastroenterol Hepatol. 2020;18:249-251.e1.PubMed Hoofien A, Papadopoulou A, Gutiérrez-Junquera C et al. Sustained remission of eosinophilic esophagitis following discontinuation of dietary elimination in children. Clin Gastroenterol Hepatol. 2020;18:249-251.e1.PubMed
45.
go back to reference Collins CA, Palmquist J, Proudfoot JA et al. Evaluation of long-term course in children with eosinophilic esophagitis reveals distinct histologic patterns and clinical characteristics. J Allergy Clin Immunol. 2019;144:1050-1057.e5.PubMedPubMedCentral Collins CA, Palmquist J, Proudfoot JA et al. Evaluation of long-term course in children with eosinophilic esophagitis reveals distinct histologic patterns and clinical characteristics. J Allergy Clin Immunol. 2019;144:1050-1057.e5.PubMedPubMedCentral
46.
go back to reference Rajan J, Newbury RO, Anilkumar A et al. Long term assessment of esophageal remodeling in pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol. 2016;137:147-156.e8.PubMed Rajan J, Newbury RO, Anilkumar A et al. Long term assessment of esophageal remodeling in pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol. 2016;137:147-156.e8.PubMed
47.
go back to reference Greuter T, Safroneeva E, Bussmann C et al. Maintenance treatment of eosinophilic esophagitis with swallowed topical steroids alters disease course over a 5-year follow-up period in adult patients. Clin Gastroenterol Hepatol. 2019;17:419-428.e6.PubMed Greuter T, Safroneeva E, Bussmann C et al. Maintenance treatment of eosinophilic esophagitis with swallowed topical steroids alters disease course over a 5-year follow-up period in adult patients. Clin Gastroenterol Hepatol. 2019;17:419-428.e6.PubMed
48.
go back to reference Lucendo AJ, Santander C, Savarino E et al. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therapeutic Advances in Gastroenterology. 2022;15:1–16. Lucendo AJ, Santander C, Savarino E et al. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therapeutic Advances in Gastroenterology. 2022;15:1–16.
49.
go back to reference Navarro P, Laserna-Mendieta EJ, Guagnozzi D et al. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Dig Liver Dis. 2021;53:1479–1485.PubMed Navarro P, Laserna-Mendieta EJ, Guagnozzi D et al. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Dig Liver Dis. 2021;53:1479–1485.PubMed
50.
go back to reference Lipka S, Kumar A, Miladinovic B et al. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016;43:663–673.PubMed Lipka S, Kumar A, Miladinovic B et al. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016;43:663–673.PubMed
51.
go back to reference Straumann A, Spichtin HP, Grize L et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669.PubMed Straumann A, Spichtin HP, Grize L et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669.PubMed
Metadata
Title
Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years
Authors
Akshatha Kiran
Brenderia A. Cameron
Zeyun Xue
Sean LaFata
Adolfo A. Ocampo
Justin McCallen
Christopher J. Lee
Stephanie A. Borinsky
Walker D. Redd
Cary C. Cotton
Swathi Eluri
Craig C. Reed
Evan S. Dellon
Publication date
15-11-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08165-z

Other articles of this Issue 2/2024

Digestive Diseases and Sciences 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.